摘要
代谢综合征(MS)患病趋势愈发严重,临床上常采用不同人体测量学指标早期诊断MS及其相关慢性病,为延缓疾病进展、提高患者生存质量提供了有效的手段。国外近期提出的心脏代谢指数(CMI)最初被证实可早期诊断糖尿病,随后研究发现其在诊断代谢综合征及其相关慢性病等方面也有重大意义,故文章就目前CMI对于MS及其相关慢性病的研究进展作一综述。
The prevalence of metabolic syndrome(MS)is becoming more and more serious.Different anthropometric indicators are often used in clinical practice to diagnose MS and its related chronic diseases at an early stage,which provides an effective means for delaying disease progression and improving the quality of life of patients.The cardiometabolic index(CMI)recently proposed abroad was initially proven to be able to diagnose diabetes at an early stage,and subsequent studies found that it is also of great significance in the diagnosis of metabolic syndrome and related chronic diseases.Therefore,this article discusses the current research on CMI for MS and related chronic diseases.
作者
王子倩(综述)
李红(审校)
Wang Ziqian;Li Hong(Department of Gastroenterology,Graduate School of Guizhou Medical University,Guizhou Province,Guiyang 550004,China;不详)
出处
《疑难病杂志》
CAS
2022年第5期539-542,共4页
Chinese Journal of Difficult and Complicated Cases
基金
国家重点研发计划“重大慢性非传染性疾病防控研究”重点专项(2017YFC1310704)。
关键词
心脏代谢指数
代谢综合征
慢性病
研究进展
诊断
Cardiac metabolism index
Metabolic syndrome
Chronic disease
Research progress
Diagnosis
